CSL books $US2b profit despite ‘sobering’ COVID conditions
MELBOURNE: Biotechnology giant CSL has booked a $US2 billion ($2.8 billion) full year profit and
MELBOURNE: Biotechnology giant CSL has booked a $US2 billion ($2.8 billion) full year profit and
FEATURED
Hospitals morphing into wellness and health precincts
Developers release plans for latest bayside living proposal
Technology will help urban spaces adapt in an ever-changing world
New funding agency to ‘supercharge’ community housing providers
Drug company deal delivers hope for dementia patients
Proactive alliances among stakeholders can lead to assisted living departments
INNOVATION
